Tekla Capital Management, formerly Hambrecht & Quist Capital Management (HQCM), is a Boston, MA based healthcare-focused investment manager with approximately $2.3 billion of assets under management as of September 30, 2014. Tekla serves as investmen...Show all
Phone: 617-772-8500
2 Liberty Square
9th Floor
Boston, 02109
Massachusetts, United States
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2020-10-15 | VectivBio | Series A | $110M | Bpifrance, Cormorant Capital, Cowen Partners Venture Fund, Eventide Asset Management, Inserm Transfert, Novo Holdings, OrbiMed Advisors, Surveyor Capital, and Versant Ventures |
2020-10-12 | Priothera | Series A | $35.39M | Earlybird Venture Capital, Fountain Healthcare Partners, and HealthCap Venture Capital |
2020-09-30 | Invetx | Series A - II | $10.25M | Casdin Capital |
2020-05-21 | HotSpot Therapeutics | Series B | $65M | Atlas Venture, Brace Pharma Capital, MRL Ventures, Sofinnova Partners, Solasta Ventures, and SR One |
2020-04-13 | Rallybio | Series B | $145M | 5AM Ventures, Canaan Partners, Connecticut Innovations, F-Prime Capital, Fairview Capital Partners, Mitsui & Co. Global Investment, New Leaf Venture Partners, Pivotal bioVenture Partners, Solasta Ventures, The Rise Fund, and Viking Global Investors |